Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
South Asian Journal of Cancer
|
March 31, 2018
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Ecancermedicalscience
|
December 1, 2016
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India
Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Govind Babu Kanakasetty, Aditi Harsh Thanky, et al.
Indian Journal of Cancer
|
May 26, 2018
Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases
K N Lokesh, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Cancer
|
May 10, 2017
Plasma cell leukemia: Single institution experience
K Govind Babu, Linu Abraham Jacob, Ankit Agarwal, et al.
South Asian Journal of Cancer
|
May 10, 2019
Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Cancer
|
January 30, 2019
Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma in adults: Results from a nonendemic region
K N Lokesh, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
January 16, 2018
Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India
A H Rudresha, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Oncotargets and Therapy
|
June 27, 2014
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study
K Govind Babu, Kumar Prabhash, Ashok K Vaid, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Indian Journal of Cancer
|
December 5, 2017
Multiple myeloma: Experience of an institute in limited resource setting
Linu Abraham Jacob, M C Suresh Babu, K C Lakshmaiah, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
South Asian Journal of Cancer
|
March 31, 2018
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Ecancermedicalscience
|
December 1, 2016
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India
Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Govind Babu Kanakasetty, Aditi Harsh Thanky, et al.
Indian Journal of Cancer
|
May 26, 2018
Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases
K N Lokesh, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Cancer
|
May 10, 2017
Plasma cell leukemia: Single institution experience
K Govind Babu, Linu Abraham Jacob, Ankit Agarwal, et al.
South Asian Journal of Cancer
|
May 10, 2019
Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Cancer
|
January 30, 2019
Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma in adults: Results from a nonendemic region
K N Lokesh, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
January 16, 2018
Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India
A H Rudresha, Tamojit Chaudhuri, K C Lakshmaiah, et al.
Oncotargets and Therapy
|
June 27, 2014
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study
K Govind Babu, Kumar Prabhash, Ashok K Vaid, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Indian Journal of Cancer
|
December 5, 2017
Multiple myeloma: Experience of an institute in limited resource setting
Linu Abraham Jacob, M C Suresh Babu, K C Lakshmaiah, et al.
Page
of 12